![Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open](https://cyberleninka.org/viewer_images/971477/f/1.png)
Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
![WO2020018959A1 - Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease - Google Patents WO2020018959A1 - Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease - Google Patents](https://patentimages.storage.googleapis.com/21/8c/21/a6ddd271250154/imgf000032_0001.png)
WO2020018959A1 - Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease - Google Patents
![PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study](https://i1.rgstatic.net/publication/279232240_L-Dopa_Pharmacokinetic_Profile_with_Effervescent_MelevodopaCarbidopa_versus_Standard-Release_LevodopaCarbidopa_Tablets_in_Parkinson's_Disease_A_Randomised_Study/links/564b21a408ae44e7a28f16dc/largepreview.png)
PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
![PDF) Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar (R)/Prolopa (R) PDF) Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar (R)/Prolopa (R)](https://www.researchgate.net/profile/Isabelle-Arnet/publication/236337142/figure/tbl2/AS:613920058392586@1523381356335/Mass-content-of-active-ingredients-and-dissolution-time-of-seven-generic-products_Q320.jpg)
PDF) Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar (R)/Prolopa (R)
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-015-1449-6/MediaObjects/702_2015_1449_Fig2_HTML.gif)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-015-1449-6/MediaObjects/702_2015_1449_Fig1_HTML.gif)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink
![Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis | HTML Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis | HTML](https://www.mdpi.com/brainsci/brainsci-11-01566/article_deploy/html/images/brainsci-11-01566-g001.png)
Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis | HTML
![Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar) - Torti - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar) - Torti - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/9eecb6e8-3cd3-4605-8cae-44cee566a8c1/bcp14086-fig-0002-m.jpg)
Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar) - Torti - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library
![References in Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial - The Lancet Neurology References in Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2092012907/2076358979/gr1.gif)